View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsHEXO 過去の業績過去 基準チェック /06HEXOの収益は年間平均-42.2%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間9.1% 39.8%割合で 増加しています。主要情報-42.20%収益成長率-4.54%EPS成長率Pharmaceuticals 業界の成長5.95%収益成長率39.79%株主資本利益率-191.40%ネット・マージン-220.13%前回の決算情報30 Apr 2023最近の業績更新Reported Earnings • Jun 16Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: CA$2.68 loss per share (improved from CA$4.69 loss in 3Q 2022). Revenue: CA$21.6m (down 53% from 3Q 2022). Net loss: CA$117.2m (loss narrowed 19% from 3Q 2022). Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Pharmaceuticals industry in the US.お知らせ • Jun 13HEXO Corp. to Report Q3, 2023 Results on Jun 14, 2023HEXO Corp. announced that they will report Q3, 2023 results After-Market on Jun 14, 2023Reported Earnings • Mar 17Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: CA$0.017 (up from CA$27.98 loss in 2Q 2022). Revenue: CA$24.2m (down 54% from 2Q 2022). Net income: CA$722.0k (up CA$711.6m from 2Q 2022). Profit margin: 3.0% (up from net loss in 2Q 2022). Revenue missed analyst estimates by 34%. Earnings per share (EPS) exceeded analyst estimates. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Pharmaceuticals industry in the US.Reported Earnings • Dec 15First quarter 2023 earnings: EPS and revenues miss analyst expectationsFirst quarter 2023 results: CA$0.094 loss per share (improved from CA$0.47 loss in 1Q 2022). Revenue: CA$35.8m (down 29% from 1Q 2022). Net loss: CA$56.3m (loss narrowed 52% from 1Q 2022). Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Pharmaceuticals industry in the US.Reported Earnings • Nov 02Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2022 results: CA$2.76 loss per share (further deteriorated from CA$0.90 loss in FY 2021). Revenue: CA$191.1m (up 54% from FY 2021). Net loss: CA$1.07b (loss widened CA$958.8m from FY 2021). Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) exceeded analyst estimates by 2.8%. Revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Pharmaceuticals industry in the US.Reported Earnings • Mar 19Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: CA$2.00 loss per share (down from CA$0.17 loss in 2Q 2021). Revenue: CA$52.8m (up 61% from 2Q 2021). Net loss: CA$710.9m (loss widened CA$690.0m from 2Q 2021). Revenue missed analyst estimates by 7.7%. Earnings per share (EPS) exceeded analyst estimates by 2,546%. Over the next year, revenue is forecast to grow 61%, compared to a 17% growth forecast for the industry in the US.すべての更新を表示Recent updatesお知らせ • Jun 24+ 1 more updateHEXO Corp.(NasdaqCM:HEXO) dropped from NASDAQ Composite IndexHEXO Corp. has been dropped from NASDAQ Composite Index..お知らせ • Jun 23HEXO Corp. announced that it has received $25 million in fundingOn June 22, 2023, HEXO Corp. closed the transaction. As on the same day, the company has issued 13,500,000 series 1 preferred shares at an issue price of $1 per share for additional gross proceeds to the $13,500,000 in second of two tranches.New Risk • Jun 16New minor risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow. Free cash flow: -CA$48m This is considered a minor risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-CA$48m). Currently unprofitable and not forecast to become profitable over next 3 years (CA$5.9m net loss in 3 years). Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (23% increase in shares outstanding). Market cap is less than US$100m (US$33.3m market cap).Reported Earnings • Jun 16Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: CA$2.68 loss per share (improved from CA$4.69 loss in 3Q 2022). Revenue: CA$21.6m (down 53% from 3Q 2022). Net loss: CA$117.2m (loss narrowed 19% from 3Q 2022). Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Pharmaceuticals industry in the US.お知らせ • Jun 13HEXO Corp. to Report Q3, 2023 Results on Jun 14, 2023HEXO Corp. announced that they will report Q3, 2023 results After-Market on Jun 14, 2023Reported Earnings • Mar 17Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: CA$0.017 (up from CA$27.98 loss in 2Q 2022). Revenue: CA$24.2m (down 54% from 2Q 2022). Net income: CA$722.0k (up CA$711.6m from 2Q 2022). Profit margin: 3.0% (up from net loss in 2Q 2022). Revenue missed analyst estimates by 34%. Earnings per share (EPS) exceeded analyst estimates. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Pharmaceuticals industry in the US.お知らせ • Feb 09HEXO Corp. Launches Enhanced Inhalation TechnologyHEXO Corp. announced that it will be launching a unique proprietary inhalation technology, intended to greatly improve the cannabis experience. The development allows HEXO to increase its straight edge pre-roll production capacity, accelerating the delivery of the immensely popular Redecan Redees products to include the new TnT cannabis strain series and expanding HEXO’s Original Stash brand to address rising consumer demand. Consumers have reacted positively to the new format and strains, and this expansion supports HEXO’s continued leadership of the Canadian straight edge pre-roll market. The Redecan Redees straight edge pre-roll is HEXO’s premium pre-roll product and Canada’s fastest growing and largest pre-roll in terms of market share. Redees are known as some of the smoothest products on the market and do not have an “after-burn” like many straight edge pre-roll products. Consumers also prefer their ease of use, appealing packaging and convenience over the more common but less consistent commodity cannabis products. Thoughtfully designed with an extra-long filter, tightly packed and offered in a convenient 10-pack, Redecan Redees are the original personal-sized straight edge pre-roll. Redecan Redees straight edge pre-rolls also now feature a unique inhalation technology, developed through comprehensive consumer research and feedback. Incorporating the new proprietary technology allows an enhanced draw and intake, further heightening the consumer experience. HEXO’s flagship Redecan Redees brand is launching several TnT strains throughout the year, including Warlock, Gluberry and Animal Rntz, along with a new 2:1 CBD:THC balanced product, CBD Kush, which offers the benefits of both cannabinoids. The brand will also continue to feature consumer favourites such as the Cold Creek Kush Redees and WappaRedees. HEXO’s Original Stash line will launch its own straight edge pre-rolls, featuring the line’s popular Atomik Sour Haze and Powdered Donuts.お知らせ • Jan 28HEXO Corp Wins Complete Dismissal of Putative Québec Shareholder Class ActionHEXO Corp. announced that it has won a complete dismissal of the putative securities class action lawsuit pending before the Québec Superior Court against the Company and its former Chief Executive Officer, filed on November 19, 2019 on behalf of certain primary market and secondary market purchasers of securities of the Company. As previously disclosed, HEXO and its former Chief Executive Officer (“Defendants”) were named in a shareholder class action lawsuit filed in the province of Québec. The lawsuit asserted causes of action for misrepresentations and breaches of disclosure obligations under the Québec Securities Act and the Civil Code of Québec in connection with certain statements contained in HEXO’s prospectus, public documents and public oral statements between April 11, 2018 and March 27, 2020. In a 48-page opinion dated January 23, 2023, the Superior Court of Québec dismissed the Plaintiff’s amended motion in its entirety, with costs. The Court agreed with the Defendants that there was “no reasonable possibility” that the secondary market claim filed under the Québec Securities Act had a reasonable chance of success, or that the Plaintiff had demonstrated an arguable case for a primary market class action or a civil liability class action “for misrepresentation under the general principles of fault in the civil law.” The Plaintiff has a right to appeal.お知らせ • Jan 10HEXO Launches Five New Cannabis Strains Under Market-Leading Redecan and Original Stash BrandsHEXO Corp. announced the launch of its new TnT Cannabis strains under the Redecan and Original Stash Brandslabels across Canada. The new strains further expand HEXO’s top-selling product portfolio and are available on retailer shelves now. The launch includes three new products from HEXO’s popular Redecan line and two new strains under the Original Stash Brand. Redecan’s hang-dried and hand-trimmed cannabis features a trailblazing THC range of 23 to 35% and high terpene profiles tailored for creativity, excitement and to help unwind. The new TnT cannabis strains will feature extremely dense buds covered in trichomes: Sex Panther (flower), an Indica hybrid strain, has a powerful effervescent cake flavour. Violet Fog (flower), a purple reign Indica strain, from the Grape Gasoline and Khalifa Mints Strains features robust fruity and sour notes. Animal Rntz (flower), a combination of Canada’s popular Animal Cookie and California’s RNTZ strains, has a fruity tartness along with a sweet and sour aroma, highlighted by astounding levels of limonene and caryophyllene terpenes. HEXO’sMaster Growers have spent the past two years optimizing cannabis genetics and cultivation techniques on their proprietary Indica and Sativa cannabis strains to maximize terpenes and THC percentages for the Canadian market. The new strains added to the Original Stash Brand line-up leverage Canada’s broadest Licensed Producer’s cultivation capabilities and include: Atomik Sour Haze (flower), Sativa strain features amazing fruity and sour notes. Ghost Gelato (flower), an Indica strain, bringing a funk smell reminiscent of old school marijuana.Reported Earnings • Dec 15First quarter 2023 earnings: EPS and revenues miss analyst expectationsFirst quarter 2023 results: CA$0.094 loss per share (improved from CA$0.47 loss in 1Q 2022). Revenue: CA$35.8m (down 29% from 1Q 2022). Net loss: CA$56.3m (loss narrowed 52% from 1Q 2022). Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Pharmaceuticals industry in the US.お知らせ • Dec 07HEXO Corp., Annual General Meeting, Jan 31, 2023HEXO Corp., Annual General Meeting, Jan 31, 2023.Board Change • Nov 16High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Nov 02Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2022 results: CA$2.76 loss per share (further deteriorated from CA$0.90 loss in FY 2021). Revenue: CA$191.1m (up 54% from FY 2021). Net loss: CA$1.07b (loss widened CA$958.8m from FY 2021). Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) exceeded analyst estimates by 2.8%. Revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Pharmaceuticals industry in the US.Breakeven Date Change • Nov 01No longer forecast to breakevenThe 9 analysts covering HEXO no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of CA$15.5m in 2025. New consensus forecast suggests the company will make a loss of CA$0 in 2025.Seeking Alpha • Aug 30Hexo to produce Mike Tyson's cannabis brand's products in CanadaHexo (NASDAQ:HEXO) said it signed an exclusive partnership with Mike Tyson's recently formed cannabis company TYSON 2.0. Under the agreement, Hexo will produce TYSON 2.0's products in Canada, including full range of flower, pre-rolls, edibles and vapes. The HEXO-produced lines will launch across Canada in fall 2022, the company said in an Aug. 30 press release. "With their broad product range from flower to straight edge pre-rolls to edibles, the TYSON 2.0 brand fits perfectly into HEXO's market leading portfolio," said Hexo CEO Charlie Bowman. HEXO +4.67% to $0.22 premarket Aug. 30Seeking Alpha • Aug 17Canopy Growth, Tilray other Canadian cannabis names up amid WallStreetBets chatterCanopy Growth (NASDAQ:CGC), Tilray Brands (NASDAQ:TLRY), and other Canadian cannabis licensed producers are markedly higher in Wednesday trading as chatter about the industry on WallStreetBets intensifies. In Wednesday morning trading, Canopy (CGC) is up 11%, Tilray (TLRY) up 4%, Aurora Cannabis (NASDAQ:ACB) up 6%, and HEXO Corp. (NASDAQ:HEXO) up 11%. There is increased discussion about Canadian LPs on WallStreetBets which may account for the increases. Tilray (TLRY) CEO Irwin Simon, in a recent interview with Yahoo Finance, said that the U.S. represents in $100B opportunity in cannabis. That opportunity could become reality if a federal marijuana legalization bill gets signed into law. Check out a recent deep dive into Tilray (TLRY) and whether the stock is a buy at this time.Seeking Alpha • Jul 28HEXO receives additional 180 calendar day grace period for regaining complianceHEXO (NASDAQ:HEXO) received an extension of 180 calendar days post expiration of initial 180 calendar days period to regain minimum bid price requirement compliance on July 25, 2022 from the Nasdaq Stock Market. The company now has time until Jan.23, 2023 to regain compliance after which the company is likely to receive notification for shares delisting. The current notification has no impact on the listing.Breakeven Date Change • Jul 21No longer forecast to breakevenThe 9 analysts covering HEXO no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of CA$7.95m in 2024. New consensus forecast suggests the company will make a loss of CA$24.7m in 2024.Board Change • Jul 21High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Seeking Alpha • Jul 05HEXO wins shareholder approval for note transaction with TilrayCanadian cannabis player HEXO Corp (NASDAQ:HEXO) announced on Tuesday that the company’s shareholders voted in favor of its previously disclosed transaction of convertible notes with its domestic rival Tilray (TLRY). ~87% of votes were in favor of approving certain terms of the deal, the company said following a reconvened special meeting of shareholders today. ~18% of the company’s common shares were represented at the meeting, which was initially scheduled for June 14. However, the meeting was adjourned to provide investors more time to evaluate the previously announced amendments to the transaction. Under the deal anticipated to close in 3Q 2022, Tilray (TLRY) is set to purchase as much as $185M of debt Hexo (HEXO) has issued to funds affiliated with HT Investments.Seeking Alpha • Apr 28HEXO: Undervalued, But With Certain Dilution RisksHEXO Corp. runs a consumer packaged goods cannabis business model with a leader position in the Canadian market and a production capacity of 150,000 kgs. HEXO has already signed supply agreements with partners overseas, so I would be expecting an increase in international sales growth in the coming years. In my view, economies of scale, more efficient automated technology, and the integration of new acquisitions will likely lead to lower cost per gram.Breakeven Date Change • Apr 11Forecast to breakeven in 2024The 9 analysts covering HEXO expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 40% per year to 2023. The company is expected to make a profit of CA$7.95m in 2024. Average annual earnings growth of 84% is required to achieve expected profit on schedule.Board Change • Apr 01High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Mar 19Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: CA$2.00 loss per share (down from CA$0.17 loss in 2Q 2021). Revenue: CA$52.8m (up 61% from 2Q 2021). Net loss: CA$710.9m (loss widened CA$690.0m from 2Q 2021). Revenue missed analyst estimates by 7.7%. Earnings per share (EPS) exceeded analyst estimates by 2,546%. Over the next year, revenue is forecast to grow 61%, compared to a 17% growth forecast for the industry in the US.Board Change • Mar 04High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Board Change • Jan 01High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Chairman of the Board John Bell was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Dec 16First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2022 results: CA$0.47 loss per share (down from CA$0.035 loss in 1Q 2021). Revenue: CA$50.2m (up 70% from 1Q 2021). Net loss: CA$117.3m (loss widened CA$113.1m from 1Q 2021). Revenue missed analyst estimates by 7.2%. Earnings per share (EPS) exceeded analyst estimates by 358%. Earnings per share (EPS) surpassed analyst estimates by 358%. Over the next year, revenue is forecast to grow 76%, compared to a 15% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has fallen by 61% per year, which means it is performing significantly worse than earnings.Seeking Alpha • Dec 14HEXO Q1 Earnings: Not A Great Path ForwardHEXO reported weak FQ1 results for the period ending Oct. 31. The addition of the businesses of Redecan and 48North didn't improve the financials or move the company any closer to being cash flow positive. The stock isn't touchable with the senior debt overhang and another restructuring in the works.Board Change • Dec 03High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. President, CEO & Director Scott Cooper was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.収支内訳HEXO の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史NasdaqCM:HEXO 収益、費用、利益 ( )CAD Millions日付収益収益G+A経費研究開発費30 Apr 23124-27361131 Jan 23148-30186131 Oct 22177-1,013105331 Jul 22191-1,074122330 Apr 22187-1,042128431 Jan 22164-918109431 Oct 21144-22896431 Jul 21124-11580430 Apr 21112-21475431 Jan 21112-21375431 Oct 2096-49178431 Jul 2081-54691530 Apr 2069-423115731 Jan 2060-411119631 Oct 1956-117114531 Jul 1948-70105330 Apr 1934-3573031 Jan 1922-3054031 Oct 189-3441031 Jul 185-2323030 Apr 184-1215031 Jan 184-2212031 Oct 174-149031 Jul 174-127030 Apr 174-157031 Jan 174-35031 Oct 163-34031 Jul 162-34031 Jul 150-320質の高い収益: HEXOは現在利益が出ていません。利益率の向上: HEXOは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: HEXOは利益が出ておらず、過去 5 年間で損失は年間42.2%の割合で増加しています。成長の加速: HEXOの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: HEXOは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( -5% ) と比較することは困難です。株主資本利益率高いROE: HEXOは現在利益が出ていないため、自己資本利益率 ( -191.4% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/06/23 17:10終値2023/06/22 00:00収益2023/04/30年間収益2022/07/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋HEXO Corp. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。19 アナリスト機関Aaron GreyAlliance Global PartnersDavid KideckelATB CormarkJesse PytlakATB Cormark Historical (Cormark Securities)16 その他のアナリストを表示
Reported Earnings • Jun 16Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: CA$2.68 loss per share (improved from CA$4.69 loss in 3Q 2022). Revenue: CA$21.6m (down 53% from 3Q 2022). Net loss: CA$117.2m (loss narrowed 19% from 3Q 2022). Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Pharmaceuticals industry in the US.
お知らせ • Jun 13HEXO Corp. to Report Q3, 2023 Results on Jun 14, 2023HEXO Corp. announced that they will report Q3, 2023 results After-Market on Jun 14, 2023
Reported Earnings • Mar 17Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: CA$0.017 (up from CA$27.98 loss in 2Q 2022). Revenue: CA$24.2m (down 54% from 2Q 2022). Net income: CA$722.0k (up CA$711.6m from 2Q 2022). Profit margin: 3.0% (up from net loss in 2Q 2022). Revenue missed analyst estimates by 34%. Earnings per share (EPS) exceeded analyst estimates. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Pharmaceuticals industry in the US.
Reported Earnings • Dec 15First quarter 2023 earnings: EPS and revenues miss analyst expectationsFirst quarter 2023 results: CA$0.094 loss per share (improved from CA$0.47 loss in 1Q 2022). Revenue: CA$35.8m (down 29% from 1Q 2022). Net loss: CA$56.3m (loss narrowed 52% from 1Q 2022). Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Pharmaceuticals industry in the US.
Reported Earnings • Nov 02Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2022 results: CA$2.76 loss per share (further deteriorated from CA$0.90 loss in FY 2021). Revenue: CA$191.1m (up 54% from FY 2021). Net loss: CA$1.07b (loss widened CA$958.8m from FY 2021). Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) exceeded analyst estimates by 2.8%. Revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Pharmaceuticals industry in the US.
Reported Earnings • Mar 19Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: CA$2.00 loss per share (down from CA$0.17 loss in 2Q 2021). Revenue: CA$52.8m (up 61% from 2Q 2021). Net loss: CA$710.9m (loss widened CA$690.0m from 2Q 2021). Revenue missed analyst estimates by 7.7%. Earnings per share (EPS) exceeded analyst estimates by 2,546%. Over the next year, revenue is forecast to grow 61%, compared to a 17% growth forecast for the industry in the US.
お知らせ • Jun 24+ 1 more updateHEXO Corp.(NasdaqCM:HEXO) dropped from NASDAQ Composite IndexHEXO Corp. has been dropped from NASDAQ Composite Index..
お知らせ • Jun 23HEXO Corp. announced that it has received $25 million in fundingOn June 22, 2023, HEXO Corp. closed the transaction. As on the same day, the company has issued 13,500,000 series 1 preferred shares at an issue price of $1 per share for additional gross proceeds to the $13,500,000 in second of two tranches.
New Risk • Jun 16New minor risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow. Free cash flow: -CA$48m This is considered a minor risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-CA$48m). Currently unprofitable and not forecast to become profitable over next 3 years (CA$5.9m net loss in 3 years). Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (23% increase in shares outstanding). Market cap is less than US$100m (US$33.3m market cap).
Reported Earnings • Jun 16Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: CA$2.68 loss per share (improved from CA$4.69 loss in 3Q 2022). Revenue: CA$21.6m (down 53% from 3Q 2022). Net loss: CA$117.2m (loss narrowed 19% from 3Q 2022). Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Pharmaceuticals industry in the US.
お知らせ • Jun 13HEXO Corp. to Report Q3, 2023 Results on Jun 14, 2023HEXO Corp. announced that they will report Q3, 2023 results After-Market on Jun 14, 2023
Reported Earnings • Mar 17Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: CA$0.017 (up from CA$27.98 loss in 2Q 2022). Revenue: CA$24.2m (down 54% from 2Q 2022). Net income: CA$722.0k (up CA$711.6m from 2Q 2022). Profit margin: 3.0% (up from net loss in 2Q 2022). Revenue missed analyst estimates by 34%. Earnings per share (EPS) exceeded analyst estimates. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Pharmaceuticals industry in the US.
お知らせ • Feb 09HEXO Corp. Launches Enhanced Inhalation TechnologyHEXO Corp. announced that it will be launching a unique proprietary inhalation technology, intended to greatly improve the cannabis experience. The development allows HEXO to increase its straight edge pre-roll production capacity, accelerating the delivery of the immensely popular Redecan Redees products to include the new TnT cannabis strain series and expanding HEXO’s Original Stash brand to address rising consumer demand. Consumers have reacted positively to the new format and strains, and this expansion supports HEXO’s continued leadership of the Canadian straight edge pre-roll market. The Redecan Redees straight edge pre-roll is HEXO’s premium pre-roll product and Canada’s fastest growing and largest pre-roll in terms of market share. Redees are known as some of the smoothest products on the market and do not have an “after-burn” like many straight edge pre-roll products. Consumers also prefer their ease of use, appealing packaging and convenience over the more common but less consistent commodity cannabis products. Thoughtfully designed with an extra-long filter, tightly packed and offered in a convenient 10-pack, Redecan Redees are the original personal-sized straight edge pre-roll. Redecan Redees straight edge pre-rolls also now feature a unique inhalation technology, developed through comprehensive consumer research and feedback. Incorporating the new proprietary technology allows an enhanced draw and intake, further heightening the consumer experience. HEXO’s flagship Redecan Redees brand is launching several TnT strains throughout the year, including Warlock, Gluberry and Animal Rntz, along with a new 2:1 CBD:THC balanced product, CBD Kush, which offers the benefits of both cannabinoids. The brand will also continue to feature consumer favourites such as the Cold Creek Kush Redees and WappaRedees. HEXO’s Original Stash line will launch its own straight edge pre-rolls, featuring the line’s popular Atomik Sour Haze and Powdered Donuts.
お知らせ • Jan 28HEXO Corp Wins Complete Dismissal of Putative Québec Shareholder Class ActionHEXO Corp. announced that it has won a complete dismissal of the putative securities class action lawsuit pending before the Québec Superior Court against the Company and its former Chief Executive Officer, filed on November 19, 2019 on behalf of certain primary market and secondary market purchasers of securities of the Company. As previously disclosed, HEXO and its former Chief Executive Officer (“Defendants”) were named in a shareholder class action lawsuit filed in the province of Québec. The lawsuit asserted causes of action for misrepresentations and breaches of disclosure obligations under the Québec Securities Act and the Civil Code of Québec in connection with certain statements contained in HEXO’s prospectus, public documents and public oral statements between April 11, 2018 and March 27, 2020. In a 48-page opinion dated January 23, 2023, the Superior Court of Québec dismissed the Plaintiff’s amended motion in its entirety, with costs. The Court agreed with the Defendants that there was “no reasonable possibility” that the secondary market claim filed under the Québec Securities Act had a reasonable chance of success, or that the Plaintiff had demonstrated an arguable case for a primary market class action or a civil liability class action “for misrepresentation under the general principles of fault in the civil law.” The Plaintiff has a right to appeal.
お知らせ • Jan 10HEXO Launches Five New Cannabis Strains Under Market-Leading Redecan and Original Stash BrandsHEXO Corp. announced the launch of its new TnT Cannabis strains under the Redecan and Original Stash Brandslabels across Canada. The new strains further expand HEXO’s top-selling product portfolio and are available on retailer shelves now. The launch includes three new products from HEXO’s popular Redecan line and two new strains under the Original Stash Brand. Redecan’s hang-dried and hand-trimmed cannabis features a trailblazing THC range of 23 to 35% and high terpene profiles tailored for creativity, excitement and to help unwind. The new TnT cannabis strains will feature extremely dense buds covered in trichomes: Sex Panther (flower), an Indica hybrid strain, has a powerful effervescent cake flavour. Violet Fog (flower), a purple reign Indica strain, from the Grape Gasoline and Khalifa Mints Strains features robust fruity and sour notes. Animal Rntz (flower), a combination of Canada’s popular Animal Cookie and California’s RNTZ strains, has a fruity tartness along with a sweet and sour aroma, highlighted by astounding levels of limonene and caryophyllene terpenes. HEXO’sMaster Growers have spent the past two years optimizing cannabis genetics and cultivation techniques on their proprietary Indica and Sativa cannabis strains to maximize terpenes and THC percentages for the Canadian market. The new strains added to the Original Stash Brand line-up leverage Canada’s broadest Licensed Producer’s cultivation capabilities and include: Atomik Sour Haze (flower), Sativa strain features amazing fruity and sour notes. Ghost Gelato (flower), an Indica strain, bringing a funk smell reminiscent of old school marijuana.
Reported Earnings • Dec 15First quarter 2023 earnings: EPS and revenues miss analyst expectationsFirst quarter 2023 results: CA$0.094 loss per share (improved from CA$0.47 loss in 1Q 2022). Revenue: CA$35.8m (down 29% from 1Q 2022). Net loss: CA$56.3m (loss narrowed 52% from 1Q 2022). Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Pharmaceuticals industry in the US.
お知らせ • Dec 07HEXO Corp., Annual General Meeting, Jan 31, 2023HEXO Corp., Annual General Meeting, Jan 31, 2023.
Board Change • Nov 16High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Nov 02Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2022 results: CA$2.76 loss per share (further deteriorated from CA$0.90 loss in FY 2021). Revenue: CA$191.1m (up 54% from FY 2021). Net loss: CA$1.07b (loss widened CA$958.8m from FY 2021). Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) exceeded analyst estimates by 2.8%. Revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Pharmaceuticals industry in the US.
Breakeven Date Change • Nov 01No longer forecast to breakevenThe 9 analysts covering HEXO no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of CA$15.5m in 2025. New consensus forecast suggests the company will make a loss of CA$0 in 2025.
Seeking Alpha • Aug 30Hexo to produce Mike Tyson's cannabis brand's products in CanadaHexo (NASDAQ:HEXO) said it signed an exclusive partnership with Mike Tyson's recently formed cannabis company TYSON 2.0. Under the agreement, Hexo will produce TYSON 2.0's products in Canada, including full range of flower, pre-rolls, edibles and vapes. The HEXO-produced lines will launch across Canada in fall 2022, the company said in an Aug. 30 press release. "With their broad product range from flower to straight edge pre-rolls to edibles, the TYSON 2.0 brand fits perfectly into HEXO's market leading portfolio," said Hexo CEO Charlie Bowman. HEXO +4.67% to $0.22 premarket Aug. 30
Seeking Alpha • Aug 17Canopy Growth, Tilray other Canadian cannabis names up amid WallStreetBets chatterCanopy Growth (NASDAQ:CGC), Tilray Brands (NASDAQ:TLRY), and other Canadian cannabis licensed producers are markedly higher in Wednesday trading as chatter about the industry on WallStreetBets intensifies. In Wednesday morning trading, Canopy (CGC) is up 11%, Tilray (TLRY) up 4%, Aurora Cannabis (NASDAQ:ACB) up 6%, and HEXO Corp. (NASDAQ:HEXO) up 11%. There is increased discussion about Canadian LPs on WallStreetBets which may account for the increases. Tilray (TLRY) CEO Irwin Simon, in a recent interview with Yahoo Finance, said that the U.S. represents in $100B opportunity in cannabis. That opportunity could become reality if a federal marijuana legalization bill gets signed into law. Check out a recent deep dive into Tilray (TLRY) and whether the stock is a buy at this time.
Seeking Alpha • Jul 28HEXO receives additional 180 calendar day grace period for regaining complianceHEXO (NASDAQ:HEXO) received an extension of 180 calendar days post expiration of initial 180 calendar days period to regain minimum bid price requirement compliance on July 25, 2022 from the Nasdaq Stock Market. The company now has time until Jan.23, 2023 to regain compliance after which the company is likely to receive notification for shares delisting. The current notification has no impact on the listing.
Breakeven Date Change • Jul 21No longer forecast to breakevenThe 9 analysts covering HEXO no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of CA$7.95m in 2024. New consensus forecast suggests the company will make a loss of CA$24.7m in 2024.
Board Change • Jul 21High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Seeking Alpha • Jul 05HEXO wins shareholder approval for note transaction with TilrayCanadian cannabis player HEXO Corp (NASDAQ:HEXO) announced on Tuesday that the company’s shareholders voted in favor of its previously disclosed transaction of convertible notes with its domestic rival Tilray (TLRY). ~87% of votes were in favor of approving certain terms of the deal, the company said following a reconvened special meeting of shareholders today. ~18% of the company’s common shares were represented at the meeting, which was initially scheduled for June 14. However, the meeting was adjourned to provide investors more time to evaluate the previously announced amendments to the transaction. Under the deal anticipated to close in 3Q 2022, Tilray (TLRY) is set to purchase as much as $185M of debt Hexo (HEXO) has issued to funds affiliated with HT Investments.
Seeking Alpha • Apr 28HEXO: Undervalued, But With Certain Dilution RisksHEXO Corp. runs a consumer packaged goods cannabis business model with a leader position in the Canadian market and a production capacity of 150,000 kgs. HEXO has already signed supply agreements with partners overseas, so I would be expecting an increase in international sales growth in the coming years. In my view, economies of scale, more efficient automated technology, and the integration of new acquisitions will likely lead to lower cost per gram.
Breakeven Date Change • Apr 11Forecast to breakeven in 2024The 9 analysts covering HEXO expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 40% per year to 2023. The company is expected to make a profit of CA$7.95m in 2024. Average annual earnings growth of 84% is required to achieve expected profit on schedule.
Board Change • Apr 01High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Mar 19Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: CA$2.00 loss per share (down from CA$0.17 loss in 2Q 2021). Revenue: CA$52.8m (up 61% from 2Q 2021). Net loss: CA$710.9m (loss widened CA$690.0m from 2Q 2021). Revenue missed analyst estimates by 7.7%. Earnings per share (EPS) exceeded analyst estimates by 2,546%. Over the next year, revenue is forecast to grow 61%, compared to a 17% growth forecast for the industry in the US.
Board Change • Mar 04High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Board Change • Jan 01High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Chairman of the Board John Bell was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Dec 16First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2022 results: CA$0.47 loss per share (down from CA$0.035 loss in 1Q 2021). Revenue: CA$50.2m (up 70% from 1Q 2021). Net loss: CA$117.3m (loss widened CA$113.1m from 1Q 2021). Revenue missed analyst estimates by 7.2%. Earnings per share (EPS) exceeded analyst estimates by 358%. Earnings per share (EPS) surpassed analyst estimates by 358%. Over the next year, revenue is forecast to grow 76%, compared to a 15% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has fallen by 61% per year, which means it is performing significantly worse than earnings.
Seeking Alpha • Dec 14HEXO Q1 Earnings: Not A Great Path ForwardHEXO reported weak FQ1 results for the period ending Oct. 31. The addition of the businesses of Redecan and 48North didn't improve the financials or move the company any closer to being cash flow positive. The stock isn't touchable with the senior debt overhang and another restructuring in the works.
Board Change • Dec 03High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. President, CEO & Director Scott Cooper was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.